vs

Side-by-side financial comparison of American Assets Trust, Inc. (AAT) and Axogen, Inc. (AXGN). Click either name above to swap in a different company.

American Assets Trust, Inc. is the larger business by last-quarter revenue ($110.6M vs $61.5M, roughly 1.8× Axogen, Inc.). American Assets Trust, Inc. runs the higher net margin — 6.1% vs -31.9%, a 38.0% gap on every dollar of revenue. On growth, Axogen, Inc. posted the faster year-over-year revenue change (26.6% vs 1.8%). Over the past eight quarters, Axogen, Inc.'s revenue compounded faster (13.3% CAGR vs -0.1%).

Personal Assets Trust is a large British investment trust. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The chairman is Iain Ferguson CBE.

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...

AAT vs AXGN — Head-to-Head

Bigger by revenue
AAT
AAT
1.8× larger
AAT
$110.6M
$61.5M
AXGN
Growing faster (revenue YoY)
AXGN
AXGN
+24.7% gap
AXGN
26.6%
1.8%
AAT
Higher net margin
AAT
AAT
38.0% more per $
AAT
6.1%
-31.9%
AXGN
Faster 2-yr revenue CAGR
AXGN
AXGN
Annualised
AXGN
13.3%
-0.1%
AAT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AAT
AAT
AXGN
AXGN
Revenue
$110.6M
$61.5M
Net Profit
$6.7M
$-19.6M
Gross Margin
75.2%
Operating Margin
23.4%
20.2%
Net Margin
6.1%
-31.9%
Revenue YoY
1.8%
26.6%
Net Profit YoY
-16.3%
-410.8%
EPS (diluted)
$0.08
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAT
AAT
AXGN
AXGN
Q1 26
$110.6M
$61.5M
Q4 25
$110.1M
$59.9M
Q3 25
$109.6M
$60.1M
Q2 25
$107.9M
$56.7M
Q1 25
$108.6M
$48.6M
Q4 24
$113.5M
$49.4M
Q3 24
$122.8M
$48.6M
Q2 24
$110.9M
$47.9M
Net Profit
AAT
AAT
AXGN
AXGN
Q1 26
$6.7M
$-19.6M
Q4 25
$-13.2M
Q3 25
$4.5M
$708.0K
Q2 25
$5.5M
$579.0K
Q1 25
$42.5M
$-3.8M
Q4 24
$450.0K
Q3 24
$16.7M
$-1.9M
Q2 24
$11.9M
$-1.9M
Gross Margin
AAT
AAT
AXGN
AXGN
Q1 26
75.2%
Q4 25
59.4%
74.1%
Q3 25
60.5%
76.6%
Q2 25
62.6%
74.2%
Q1 25
62.0%
71.9%
Q4 24
61.3%
76.1%
Q3 24
65.5%
74.9%
Q2 24
63.6%
73.8%
Operating Margin
AAT
AAT
AXGN
AXGN
Q1 26
23.4%
20.2%
Q4 25
21.1%
-16.3%
Q3 25
22.6%
3.2%
Q2 25
24.1%
3.0%
Q1 25
66.3%
-3.4%
Q4 24
26.5%
4.1%
Q3 24
30.8%
-0.6%
Q2 24
27.8%
-0.9%
Net Margin
AAT
AAT
AXGN
AXGN
Q1 26
6.1%
-31.9%
Q4 25
-22.0%
Q3 25
4.1%
1.2%
Q2 25
5.1%
1.0%
Q1 25
39.2%
-7.9%
Q4 24
0.9%
Q3 24
13.6%
-3.8%
Q2 24
10.7%
-4.0%
EPS (diluted)
AAT
AAT
AXGN
AXGN
Q1 26
$0.08
$-0.38
Q4 25
$0.06
$-0.28
Q3 25
$0.07
$0.01
Q2 25
$0.09
$0.01
Q1 25
$0.70
$-0.08
Q4 24
$0.14
$-0.00
Q3 24
$0.28
$-0.04
Q2 24
$0.20
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAT
AAT
AXGN
AXGN
Cash + ST InvestmentsLiquidity on hand
$118.3M
$82.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$244.8M
Total Assets
$2.9B
$289.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAT
AAT
AXGN
AXGN
Q1 26
$118.3M
$82.7M
Q4 25
$129.4M
$41.5M
Q3 25
$138.7M
$35.8M
Q2 25
$143.7M
$29.9M
Q1 25
$143.9M
$22.1M
Q4 24
$425.7M
$33.5M
Q3 24
$533.0M
$24.5M
Q2 24
$114.9M
$21.1M
Total Debt
AAT
AAT
AXGN
AXGN
Q1 26
Q4 25
$1.7B
$48.4M
Q3 25
$48.2M
Q2 25
$47.9M
Q1 25
$47.7M
Q4 24
$2.0B
$47.5M
Q3 24
$47.3M
Q2 24
$47.0M
Stockholders' Equity
AAT
AAT
AXGN
AXGN
Q1 26
$1.1B
$244.8M
Q4 25
$1.2B
$128.8M
Q3 25
$1.2B
$120.8M
Q2 25
$1.2B
$112.3M
Q1 25
$1.2B
$105.4M
Q4 24
$1.2B
$103.9M
Q3 24
$1.2B
$99.4M
Q2 24
$1.2B
$95.7M
Total Assets
AAT
AAT
AXGN
AXGN
Q1 26
$2.9B
$289.5M
Q4 25
$2.9B
$221.7M
Q3 25
$2.9B
$216.4M
Q2 25
$3.0B
$205.5M
Q1 25
$3.0B
$196.2M
Q4 24
$3.3B
$203.7M
Q3 24
$3.4B
$192.0M
Q2 24
$3.0B
$188.9M
Debt / Equity
AAT
AAT
AXGN
AXGN
Q1 26
Q4 25
1.48×
0.38×
Q3 25
0.40×
Q2 25
0.43×
Q1 25
0.45×
Q4 24
1.72×
0.46×
Q3 24
0.48×
Q2 24
0.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAT
AAT
AXGN
AXGN
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-1.4M
FCF MarginFCF / Revenue
-2.3%
Capex IntensityCapex / Revenue
14.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAT
AAT
AXGN
AXGN
Q1 26
Q4 25
$167.1M
$3.0M
Q3 25
$40.5M
$3.2M
Q2 25
$49.2M
$7.7M
Q1 25
$36.9M
$-13.2M
Q4 24
$207.1M
$8.7M
Q3 24
$52.4M
$3.9M
Q2 24
$59.3M
$4.2M
Free Cash Flow
AAT
AAT
AXGN
AXGN
Q1 26
$-1.4M
Q4 25
$94.9M
$1.8M
Q3 25
$23.1M
$1.7M
Q2 25
$28.4M
$7.0M
Q1 25
$20.4M
$-13.4M
Q4 24
$136.9M
$8.1M
Q3 24
$28.0M
$3.3M
Q2 24
$43.6M
$3.3M
FCF Margin
AAT
AAT
AXGN
AXGN
Q1 26
-2.3%
Q4 25
86.2%
3.0%
Q3 25
21.1%
2.8%
Q2 25
26.3%
12.4%
Q1 25
18.8%
-27.7%
Q4 24
120.7%
16.3%
Q3 24
22.8%
6.8%
Q2 24
39.3%
6.8%
Capex Intensity
AAT
AAT
AXGN
AXGN
Q1 26
14.5%
Q4 25
65.6%
2.1%
Q3 25
15.9%
2.5%
Q2 25
19.3%
1.3%
Q1 25
15.1%
0.5%
Q4 24
61.9%
1.4%
Q3 24
19.9%
1.2%
Q2 24
14.1%
1.9%
Cash Conversion
AAT
AAT
AXGN
AXGN
Q1 26
Q4 25
Q3 25
8.98×
4.55×
Q2 25
9.01×
13.35×
Q1 25
0.87×
Q4 24
19.41×
Q3 24
3.15×
Q2 24
4.98×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AAT
AAT

Rental income$104.4M94%
Other$6.2M6%

AXGN
AXGN

Segment breakdown not available.

Related Comparisons